Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy

Abstract

Allelic losses occurring in cancer cells have been suggested as potential targets for therapy. Here, the authors show how recurring loss of heterozygosity of a drug metabolic gene in colorectal cancers can be exploited using a low molecular weight compound.